₹ 4,872.30
-29.20 (-0.6%)Open
4949.55High
5021.85Low
4864.9Prev Close
4901.5P/E
37.32Median P/E
30.61P/B
6.49Median P/B
4.51Market Cap
582.56BPEG
1.01Div.Yield
0.92Bid
-Ask
-Large Cap
582.56B Mkt. Cap.Volatility
-Beta
0.6Genie Says
Influencer Count
-Days | BSE | NSE |
---|
5 | 4,690.00 | 4,693.63 |
10 | 4,748.23 | 4,751.45 |
20 | 4,832.56 | 4,834.32 |
50 | 5,033.05 | 5,035.28 |
100 | 4,984.47 | 4,986.53 |
300 | 4,383.32 | 4,384.81 |
BSE
539523NSE
ALKEMISIN
INE540L01014Alkem Laboratories Limited is an India-based company, which is engaged in the pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The Company offers its products across various therapeutic areas, such as Anti Infective, Dermatology, Diabetology, Cardiology, Gastroenterology, Osteoporosis, Rheumatology, central nervous system (CNS), Oncology, Urology, Gynecology, and Vitamins, Mineral and Nutrition. Its product range includes Rx Products, Alkem Generics and OTC Product. The Company’s product portfolio includes brands, such as Clavam, Pan, Pan-D, Taxim-O, A To Z NS, Xone, Taxim, Gemcal, Pipzo and Ondem. The Company operates through a segment, Pharmaceuticals. It has approximately 21 manufacturing facilities at multiple locations in India and the United States. The Company has approximately 800 brands and operates in 40 countries.
Basudeo Singh
Executive Chairman of the BoardVikas Gupta
Chief Executive OfficerNitin Agrawal
Chief Financial OfficerManish Narang
President - Legal, Chief Compliance Officer, Company SecretarySandeep Singh
Managing Director, Executive DirectorMadhurima Singh
Executive DirectorMritunjay Singh
Executive DirectorSarvesh Singh
Executive DirectorSrinivas Singh
Executive Director